Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients

International Urology and Nephrology

Volumn 47, Issue 1, 2015, Pages 169-176

  Dusilová Sulková, Sylvie ^a   Šafránek, Roman ^a   Vávrová, Jaroslava ^a   Horáček, Jiří ^a   Pavlíková, Ladislava ^a   Palička, Vladimír ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Cholecalciferol; Dual vitamin D therapy; Haemodialysis; Parathyroid hormone; Paricalcitol; Vitamin D supplementation

Indexed keywords

ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENT; CALCIFEDIOL; CALCITRIOL RECEPTOR; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; VITAMIN;

AGED; AGONISTS; BLOOD; COMPLICATION; DIET SUPPLEMENTATION; DRUG COMBINATION; FEMALE; HUMAN; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

AGED; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; CALCIFEDIOL; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; ERGOCALCIFEROLS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RECEPTORS, CALCITRIOL; RENAL DIALYSIS; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84929620761     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0842-7     Document Type: Article

References (29)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
2. González EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24:503–510
3. Armas LAG, Andukuri R, Barger-Lux J, Heaney RP, Lund R (2012) 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol 7:1428–1434
4. Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Letz TH, Weiner SM, Rump LC (2008) High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 23:4016–4020
5. Jones G (2010) Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analog? Semin Dial 23:239–243
6. Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barre M, Pichette V (2010) Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 21:1488–1497
7. Jean G, Vanel T, Terrat JC, Chazot C (2010) Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial Int 14:486–491
8. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613–620
9. Anand S, Chertow GM, Johansen KL, Grimes B, Darlymple LS, Kaysen A, Kurela Tamura M (2013) Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study. J Ren Nutr 23:422–427
10. Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, Wanner C, Boeschoten EW, Brandenburg V, for the NECOSAD Study Group (2011) Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 26:1024–1032
11. Pilz S, Tomaschitz A, Friedl C, Amrein K, Drechsler C, Ritz E, Boehm BO, Grammer TB, Maerz W (2011) Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 26:3603–3609
12. Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38:323–329
13. Kandula P, Dobre M, Schold JD, Scheiber MJ, Mehrotra R, Navaneethan SD (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50–62
14. Szeto CC, Kam-Tao Li P (2009) The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism. NDT Plus. doi:10.1093/ndtplus/sfp034
15. Melamed ML, Thadhani RI (2012) Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol 7:358–365
16. Nigwekar SU, Bhan I, Thadhani R (2012) Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 60:139–156
17. Moorthi RN, Kandula P, Moe SM (2011) Optimal vitamin D, calcitriol and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question. Curr Opin Nephrol Hypertens 20:354–359
18. Vondracek SF, Hoody DW (2011) Combination vitamin D therapy in stage 5 chronic kidney disease. Ann Pharmacother 45:1011–1015
19. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C (2008) Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75:88–95
20. Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, Jespersen J, Nybo M, Rasmussen LM, Hansen D, Scholze A (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523–3531
21. Delanaye P, Weeker L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski JM, Cavalier E (2013) Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant 28:1779–1786
22. Gardham C, Stevens PE, Delaney MP, LeRoux M, Coleman A, Lamb EJ (2010) Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol 5:1261–1267
23. Sardiwal S, Gardham C, Coleman AE, Stevens PE, Delaney MP, Lamb EJ (2012) Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int 82:100–105
24. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A (2010) Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5:905–911
25. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW (2007) Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in haemodialysis patients. Nephron Clin Pract 105:132–138
26. Armas LAG, Zena M, Lund R, Heaney RP (2013) Calcium absorption response to cholecalciferol supplementation in haemodialysis. Clin J Am Soc Nephrol 8:1003–1008
27. Braunlin W, Zhorow E, Guo A, Apruzzese W, Xu Q, Hook P, Smisek DL, Mandeville HM, Holmes-Farley SR (2002) Bile acid binging to sevelamer HCl. Kidney Int 62:611–619
28. Jean G, Souberbielle JC, Chazot C (2009) Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 24:3799–3805
29. Massart A, Debelle FD, Racape J, Gervy C, Husson C, Dhaene M, Wissing KM, Nortier JL (2014) Biochemical parameters after cholecalciferol repletion in hemodialysis: Results from the VitaDial randomized trial. Am J Kidney Dis. doi:10.1053/j.ajkd.2014.04.020